Overall (N=43) | MDII users (N=23) | CSII users (N=20) | P value* | |
Agem, median (IQR), years | 32.0 (23.0–43.0) | 38.0 (25.0–43.0) | 27.0 (22.0–43.5) | 0.25† |
Female, n (%) | 23 (53.5) | 8 (34.8) | 15 (75.0) | 0.008‡ |
Body mass index, n (%), kg/m2 | 0.19§ | |||
<18.5 | 3 (7.0) | 3 (13.0) | 0 (0.0) | |
18.5–25 | 23 (53.5) | 12 (52.2) | 11 (55.0) | |
25–30 | 8 (18.6) | 3 (13.0) | 5 (25.0) | |
30–35 | 7 (16.3) | 5 (21.7) | 2 (10.0) | |
>35 | 2 (4.7) | 0 (0.0) | 2 (10.0) | |
Caucasian race, n (%) | 34 (79.1) | 16 (69.6) | 18 (90) | 0.14§ |
Education level, n (%) | 0.20§ | |||
High school | 20 (47.6) | 12 (54.5) | 8 (40.0) | |
Bachelors | 19 (45.3) | 10 (45.5) | 9 (45.0) | |
Masters | 3 (7.1) | 0 (0.0) | 3 (15.0) |
Statistics presented as mean±SD, median (P25, P75) or n (column %).
*The p values correspond to the comparison between with pump and without pump groups.
†Kruskal-Wallis test.
‡Pearson's χ2 test.
§Fisher’s exact test.
CSII, continuous subcutaneous insulin infusion; MDII, multiple daily insulin injection.